673 P P (Cabergoline 0.5 mg)
Pill with imprint 673 P P is White, Elliptical / Oval and has been identified as Cabergoline 0.5 mg. It is supplied by Par Pharmaceutical Inc..
Cabergoline is used in the treatment of hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Cabergoline 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 673 P P
Cabergoline
- Imprint:
- 673 P P
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical Inc.
- Inactive Ingredients:
- citric acid
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about cabergoline
- Cabergoline Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 51 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Dostinex
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
